Transcranial Pulse Stimulation for Parkinson's Disease

Palo Alto (17 mi)

Age: 18+

Sex: Any

Travel: May be covered

Time Reimbursement: Varies

Trial Phase: N/A

Waitlist Available

Sponsor: Spaulding Rehabilitation Hospital

No Placebo Group

Trial Summary

What is the purpose of this trial?The investigators are studying if Transcranial Pulse Stimulation (TPS) can improve various symptoms, including movement problems, thinking abilities, mood, fatigue, freezing while walking, voice quality, and issues with smell and taste. Previous research suggests TPS might help in Alzheimer's disease and could be helpful for Parkinson's as well. Investigators will check if TPS is safe, practical, and if it makes a noticeable difference in these symptoms compared to before the treatment.

Eligibility Criteria

This trial is for individuals with Parkinson's disease who experience symptoms like movement issues, cognitive decline, mood changes, fatigue, walking difficulties, voice problems, and altered smell and taste. The exact eligibility criteria are not provided.

Inclusion Criteria

I am between 40 and 90 years old.

My Parkinson's disease is at a moderate to severe stage.

I have been on the same Parkinson's disease medication for at least 30 days.

Exclusion Criteria

I have epilepsy or a condition that makes seizures likely.

I am confined to a bed or wheelchair.

I have had brain surgery or have a malignant brain tumor.

Treatment Details

The study investigates Transcranial Pulse Stimulation (TPS) to see if it can improve a range of Parkinson's symptoms from motor function to sensory experiences. It aims to assess the safety and effectiveness of TPS in enhancing life quality for patients.

1Treatment groups

Experimental Treatment

Group I: TPSExperimental Treatment1 Intervention